Optimized electroporation of CRISPR-Cas9/gRNA ribonucleoprotein complex for selection-free homologous recombination in human pluripotent stem cells

Bamshad, M.J., Ng, S.B., Bigham, A.W., Tabor,

H.K., Emond, M.J., Nickerson, D.A., and Shendure,

J. (2011). Exome sequencing as a tool for

Mendelian disease gene discovery. Nat. Rev.

Genet. 12, 745–755. https://doi.org/10.1038/

nrg3031.

Branda, C.S., and Dymecki, S.M. (2004). Talking

about a revolution: the impact of site-specific

recombinases on genetic analyses in mice. Dev.

Cell 6, 7–28. https://doi.org/10.1016/s15345807(03)00399-x.

iPS and myogenic cells. Nucleic Acids Res. 46,

8275–8298. https://doi.org/10.1093/nar/gky548.

Doench, J.G., Hartenian, E., Graham, D.B.,

Tothova, Z., Hegde, M., Smith, I., Sullender, M.,

Ebert, B.L., Xavier, R.J., and Root, D.E. (2014).

Rational design of highly active sgRNAs for

CRISPR-Cas9-mediated gene inactivation. Nat.

Biotechnol. 32, 1262–1267. https://doi.org/10.

1038/nbt.3026.

Brinkman, E.K., Chen, T., Amendola, M., and van

Steensel, B. (2014). Easy quantitative assessment of

genome editing by sequence trace

decomposition. Nucleic Acids Res. 42, e168.

https://doi.org/10.1093/nar/gku936.

Gee, P., Lung, M.S.Y., Okuzaki, Y., Sasakawa, N.,

Iguchi, T., Makita, Y., Hozumi, H., Miura, Y., Yang,

L.F., Iwasaki, M., et al. (2020). Extracellular

nanovesicles for packaging of CRISPR-Cas9 protein

and sgRNA to induce therapeutic exon skipping.

Nat. Commun. 11, 1334. https://doi.org/10.1038/

s41467-020-14957-y.

Collins, F.S., Guyer, M.S., and Chakravarti, A.

(1997). Variations on a theme: cataloging human

DNA sequence variation. Science 278, 1580–1581.

https://doi.org/10.1126/science.278.5343.1580.

Gutschner, T., Haemmerle, M., Genovese, G.,

Draetta, G.F., and Chin, L. (2016). Post-translational

regulation of Cas9 during G1 enhances homologydirected repair. Cell Rep. 14, 1555–1566. https://

doi.org/10.1016/j.celrep.2016.01.019.

Concordet, J.P., and Haeussler, M. (2018).

CRISPOR: intuitive guide selection for CRISPR/

Cas9 genome editing experiments and screens.

Nucleic Acids Res. 46, W242–W245. https://doi.

org/10.1093/nar/gky354.

Dastidar, S., Ardui, S., Singh, K., Majumdar, D.,

Nair, N., Fu, Y., Reyon, D., Samara, E., Gerli, M.F.M.,

Klein, A.F., et al. (2018). Efficient CRISPR/Cas9mediated editing of trinucleotide repeat

expansion in myotonic dystrophy patient-derived

22

Howden, S.E., McColl, B., Glaser, A., Vadolas, J.,

Petrou, S., Little, M.H., Elefanty, A.G., and Stanley,

E.G. (2016). A Cas9 variant for efficient generation

of indel-free knockin or gene-corrected human

pluripotent stem cells. Stem Cell Reports 7,

508–517. https://doi.org/10.1016/j.stemcr.2016.07.

001.

Ishida, K., Xu, H., Sasakawa, N., Lung, M.S.Y.,

Kudryashev, J.A., Gee, P., and Hotta, A. (2018). Sitespecific randomization of the endogenous genome

STAR Protocols 2, 100965, December 17, 2021

by a regulatable CRISPR-Cas9 piggyBac system in

human cells. Sci. Rep. 8, 310. https://doi.org/10.

1038/s41598-017-18568-4.

Kagita, A., Lung, M.S.Y., Xu, H., Kita, Y., Sasakawa,

N., Iguchi, T., Ono, M., Wang, X.H., Gee, P., and

Hotta, A. (2021). Efficient ssODN-mediated

targeting by avoiding cellular inhibitory RNAs

through precomplexed CRISPR-Cas9/sgRNA

ribonucleoprotein. Stem Cell Reports 16, 985–996.

https://doi.org/10.1016/j.stemcr.2021.02.013.

Kim, S., Kim, D., Cho, S.W., Kim, J., and Kim, J.S.

(2014). Highly efficient RNA-guided genome

editing in human cells via delivery of purified Cas9

ribonucleoproteins. Genome Res. 24, 1012–1019.

https://doi.org/10.1101/gr.171322.113.

Li, H.L., Fujimoto, N., Sasakawa, N., Shirai, S.,

Ohkame, T., Sakuma, T., Tanaka, M., Amano, N.,

Watanabe, A., Sakurai, H., et al. (2015). Precise

correction of the dystrophin gene in duchenne

muscular dystrophy patient induced pluripotent

stem cells by TALEN and CRISPR-Cas9. Stem Cell

Reports 4, 143–154. https://doi.org/10.1016/j.

stemcr.2014.10.013.

Mao, Z., Bozzella, M., Seluanov, A., and

Gorbunova, V. (2008). DNA repair by

nonhomologous end joining and homologous

recombination during cell cycle in human cells. Cell

Cycle 7, 2902–2906. https://doi.org/10.4161/cc.7.

18.6679.

Miyaoka, Y., Berman, J.R., Cooper, S.B., Mayerl,

S.J., Chan, A.H., Zhang, B., Karlin-Neumann, G.A.,

A Self-archived copy in

Kyoto University Research Information Repository

https://repository.kulib.kyoto-u.ac.jp

ll

Protocol

and Conklin, B.R. (2016). Systematic quantification

of HDR and NHEJ reveals effects of locus, nuclease,

and cell type on genome-editing. Sci. Rep. 6,

23549. https://doi.org/10.1038/srep23549.

Naito, Y., Hino, K., Bono, H., and Ui-Tei, K. (2015).

CRISPRdirect: software for designing CRISPR/Cas

guide RNA with reduced off-target sites.

Bioinformatics 31, 1120–1123. https://doi.org/10.

1093/bioinformatics/btu743.

Nakagawa, M., Taniguchi, Y., Senda, S., Takizawa,

N., Ichisaka, T., Asano, K., Morizane, A., Doi, D.,

Takahashi, J., Nishizawa, M., et al. (2014). A novel

efficient feeder-free culture system for the

derivation of human induced pluripotent stem

cells. Sci. Rep. 4, 3594. https://doi.org/10.1038/

srep03594.

Okita, K., Matsumura, Y., Sato, Y., Okada, A.,

Morizane, A., Okamoto, S., Hong, H., Nakagawa,

M., Tanabe, K., Tezuka, K., et al. (2011). A more

efficient method to generate integration-free

human iPS cells. Nat. Methods 8, 409–412. https://

doi.org/10.1038/nmeth.1591.

Paix, A., Folkmann, A., Goldman, D.H., Kulaga, H.,

Grzelak, M.J., Rasoloson, D., Paidemarry, S., Green,

R., Reed, R.R., and Seydoux, G. (2017). Precision

genome editing using synthesis-dependent repair

of Cas9-induced DNA breaks. Proc. Natl. Acad. Sci.

U S A 114, E10745–E10754. https://doi.org/10.

1073/pnas.1711979114.

Paquet, D., Kwart, D., Chen, A., Sproul, A., Jacob,

S., Teo, S., Olsen, K.M., Gregg, A., Noggle, S., and

Tessier-Lavigne, M. (2016). Efficient introduction of

specific homozygous and heterozygous mutations

using CRISPR/Cas9. Nature 533, 125–129. https://

doi.org/10.1038/nature17664.

OPEN ACCESS

Ran, F.A., Hsu, P.D., Wright, J., Agarwala, V., Scott,

D.A., and Zhang, F. (2013). Genome engineering

using the CRISPR-Cas9 system. Nat. Protoc. 8,

2281–2308. https://doi.org/10.1038/nprot.2013.

143.

Richardson, C.D., Ray, G.J., DeWitt, M.A., Curie,

G.L., and Corn, J.E. (2016). Enhancing homologydirected genome editing by catalytically active and

inactive CRISPR-Cas9 using asymmetric donor

DNA. Nat. Biotechnol. 34, 339–344. https://doi.

org/10.1038/nbt.3481.

Sauer, B., and Henderson, N. (1988). Site-specific

DNA recombination in mammalian cells by the Cre

recombinase of bacteriophage P1. Proc. Natl.

Acad. Sci. U S A 85, 5166–5170. https://doi.org/10.

1073/pnas.85.14.5166.

Soldner, F., and Jaenisch, R. (2018). Stem cells,

genome editing, and the path to translational

medicine. Cell 175, 615–632. https://doi.org/10.

1016/j.cell.2018.09.010.

Untergasser, A., Cutcutache, I., Koressaar, T., Ye, J.,

Faircloth, B.C., Remm, M., and Rozen, S.G. (2012).

Primer3—new capabilities and interfaces. Nucleic

Acids Res. 40, e115. https://doi.org/10.1093/nar/

gks596.

Wang, T., Wei, J.J., Sabatini, D.M., and Lander, E.S.

(2014). Genetic screens in human cells using the

CRISPR-Cas9 system. Science 343, 80–84. https://

doi.org/10.1126/science.1246981.

Watanabe, K., Ueno, M., Kamiya, D., Nishiyama, A.,

Matsumura, M., Wataya, T., Takahashi, J.B.,

Nishikawa, S., Nishikawa, S., Muguruma, K., and

Sasai, Y. (2007). A ROCK inhibitor permits survival

of dissociated human embryonic stem cells. Nat.

Biotechnol. 25, 681–686. https://doi.org/10.1038/

nbt1310.

Xu, H., Wang, B., Ono, M., Kagita, A., Fujii, K.,

Sasakawa, N., Ueda, T., Gee, P., Nishikawa, M.,

Nomura, M., et al. (2019). Targeted Disruption of

HLA Genes via CRISPR-Cas9 Generates iPSCs with

Enhanced Immune Compatibility. Cell Stem Cell

24, 566–578. https://doi.org/10.1016/j.stem.2019.

02.005.

Ye, J., Coulouris, G., Zaretskaya, I., Cutcutache, I.,

Rozen, S., and Madden, T.L. (2012). Primer-BLAST:

a tool to design target-specific primers for

polymerase chain reaction. BMC Bioinformatics

13, 134. https://doi.org/10.1186/1471-2105-13134.

Zetsche, B., Gootenberg, J.S., Abudayyeh, O.O.,

Slaymaker, I.M., Makarova, K.S., Essletzbichler, P.,

Volz, S.E., Joung, J., van der Oost, J., Regev, A.,

et al. (2015). Cpf1 is a single RNA-guided

endonuclease of a class 2 CRISPR-Cas system. Cell

163, 759–771. https://doi.org/10.1016/j.cell.2015.

09.038.

Zhong, A., Li, M., and Zhou, T. (2020). Protocol

for the generation of human pluripotent reporter

cell lines using CRISPR/Cas9. STAR Protoc. 1,

100052. https://doi.org/10.1016/j.xpro.2020.

100052.

Zuris, J.A., Thompson, D.B., Shu, Y., Guilinger, J.P.,

Bessen, J.L., Hu, J.H., Maeder, M.L., Joung, J.K.,

Chen, Z.Y., and Liu, D.R. (2015). Cationic lipidmediated delivery of proteins enables efficient

protein-based genome editing in vitro and in vivo.

Nat. Biotechnol. 33, 73–80. https://doi.org/10.

1038/nbt.3081.

STAR Protocols 2, 100965, December 17, 2021

23

...